StockData
Cumberland Pharmaceuticals Inc logo

Cumberland Pharmaceuticals Inc (CPIX) stock

CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30225% above fair value
$6.57+0.77 (+13.28%)

Close on Nov 18, 2026Market cap $98.44MP/E –Yield –

Cumberland Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Cumberland Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was $683.90K, down 90.3% year over year. For fiscal 2025 it was $4.83M. Over ten years it grew -1.7% a year on average. The highest annual figure on record is $8.46M in fiscal 2011.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.83M–
FY2024Dec 31, 2024-$678.65K-111.7%
FY2023Dec 31, 2023$5.81M-30.4%
FY2022Dec 31, 2022$8.35M+33.9%
FY2021Dec 31, 2021$6.24M+18.3%
FY2020Dec 31, 2020$5.27M+87.7%
FY2019Dec 31, 2019$2.81M+5.8%
FY2018Dec 31, 2018$2.66M–
FY2017Dec 31, 2017-$833.67K-290.1%
FY2016Dec 31, 2016$438.61K-92.4%
FY2015Dec 31, 2015$5.73M-12.2%
FY2014Dec 31, 2014$6.53M+906.6%
FY2013Dec 31, 2013$648.71K-90.3%
FY2012Dec 31, 2012$6.67M-21.2%
FY2011Dec 31, 2011$8.46M–
FY2010Dec 31, 2010-$230.50K–
FY2009Dec 31, 2009-$196.83K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$130.46K-84.0%
Q1 FY2026Mar 31, 2026$387.03K-89.9%
Q4 FY2025Dec 31, 2025$3.03K-99.8%
Q3 FY2025Sep 30, 2025$163.39K-64.5%
Q2 FY2025Jun 30, 2025$817.32K–
Q1 FY2025Mar 31, 2025$3.85M–
Q4 FY2024Dec 31, 2024$1.90M+91.9%
Q3 FY2024Sep 30, 2024$460.12K-61.1%
Q2 FY2024Jun 30, 2024-$862.84K-116.7%
Q1 FY2024Mar 31, 2024-$2.18M–
Q4 FY2023Dec 31, 2023$991.45K-73.9%
Q3 FY2023Sep 30, 2023$1.18M-53.5%
Q2 FY2023Jun 30, 2023$5.16M+135.4%
Q1 FY2023Mar 31, 2023-$1.53M–
Q4 FY2022Dec 31, 2022$3.79M+94.4%
Q3 FY2022Sep 30, 2022$2.54M–
Q2 FY2022Jun 30, 2022$2.19M-18.3%
Q1 FY2022Mar 31, 2022-$177.48K-110.0%
Q4 FY2021Dec 31, 2021$1.95M+141.3%
Q3 FY2021Sep 30, 2021-$161.96K-119.9%
Q2 FY2021Jun 30, 2021$2.68M-3.7%
Q1 FY2021Mar 31, 2021$1.77M+104.0%
Q4 FY2020Dec 31, 2020$808.29K+4.0%
Q3 FY2020Sep 30, 2020$812.76K+23.7%
Q2 FY2020Jun 30, 2020$2.79M+55.8%
Q1 FY2020Mar 31, 2020$865.81K–
Q4 FY2019Dec 31, 2019$777.21K-77.4%
Q3 FY2019Sep 30, 2019$657.09K–
Q2 FY2019Jun 30, 2019$1.79M+136.2%
Q1 FY2019Mar 31, 2019-$413.21K-393.7%
Q4 FY2018Dec 31, 2018$3.44M–
Q3 FY2018Sep 30, 2018-$1.68M-274.5%
Q2 FY2018Jun 30, 2018$757.28K–
Q1 FY2018Mar 31, 2018$140.71K-89.3%
Q4 FY2017Dec 31, 2017-$562.62K-171.5%
Q3 FY2017Sep 30, 2017$963.09K+262.3%
Q2 FY2017Jun 30, 2017-$2.55M–
Q1 FY2017Mar 31, 2017$1.32M–
Q4 FY2016Dec 31, 2016$787.20K–
Q3 FY2016Sep 30, 2016$265.80K–

More Cumberland Pharmaceuticals figures

See a number that looks wrong?